Skip to main content
David Davidson, MD, Cardiology, Evanston, IL, Evanston Hospital

DavidJeremyDavidsonMD

Cardiology Evanston, IL

Adult Congenital Heart Disease

Physician

Dr. Davidson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Davidson's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Cardiovascular Disease, 2010 - 2013
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 2007 - 2010
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 2007

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2007 - 2026
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013

Publications & Presentations

PubMed

Press Mentions

  • Anticoagulants, Blood Thinners, and Coronavirus: Do These Medications Make You High Risk for COVID-19?
    Anticoagulants, Blood Thinners, and Coronavirus: Do These Medications Make You High Risk for COVID-19?March 20th, 2020
  • Akcea Announces Publication of Study Results Showing Multiple Benefits of Patient-to-Patient Connectivity in FCS
    Akcea Announces Publication of Study Results Showing Multiple Benefits of Patient-to-Patient Connectivity in FCSJuly 31st, 2018
  • Bluebird Bio Gibt Auf Der Jahrestagung Der European Hematology Association (EHA) Erste Daten Aus Der Phase-3-Studie Northstar-2 (HGB-207) Zur Gentherapie LentiGlobinTM Bekannt
    Bluebird Bio Gibt Auf Der Jahrestagung Der European Hematology Association (EHA) Erste Daten Aus Der Phase-3-Studie Northstar-2 (HGB-207) Zur Gentherapie LentiGlobinTM BekanntJune 28th, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations